Table 1.
Time intervals used for classifying timeliness of vaccine doses received by surveyed children, using the nationally recommended ages for vaccination, Timor Leste, 2016.1
Vaccine | Scheduled age of vaccination | Too early | Timely | Late |
---|---|---|---|---|
Birth dose | ||||
BCG2 | Birth | - | 0–30 days | 30–365 days |
OPV3 | 0–14 days | 14–365 days | ||
First dose | 6 weeks (42 days) |
<42 days | 42–56 days | ≥57 days |
OPV3 | ||||
Pentavalent vaccine4 | ||||
Second dose | 10 weeks (70 days) |
<70 days | 70–84 days | ≥85 days |
OPV3 | ||||
Pentavalent vaccine4 | ||||
Third dose | 14 weeks (98 days) |
<98 days | 98–112 days | ≥113 days |
OPV3 | ||||
Pentavalent vaccine4 | ||||
MR15 | 9 months (270 days) |
<270 days | 270–365 days | ≥366 days |
The table does not comprehensively include all vaccines listed in the national immunization schedule for children <24 months; newly introduced vaccines (as of 2016) were excluded (hepatitis B birth dose, inactivated polio vaccine, measles and rubella vaccine second dose, and diphtheria-tetanus-pertussis vaccine fourth dose).
Bacille Calmette-Guerin (BCG) vaccine.
Oral poliovirus vaccine (OPV).
Diphtheria-tetanus-pertussis-hepatitis B-Haemophilus influenzae type b (pentavalent) vaccine.
Measles and rubella vaccine first dose (MR1).